login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
METSERA INC (MTSR) Stock News
USA
- NASDAQ:MTSR -
US59267L1070
-
Common Stock
70.5
USD
-0.25 (-0.35%)
Last: 11/13/2025, 8:00:02 PM
70.65
USD
+0.15 (+0.21%)
After Hours:
11/13/2025, 8:00:02 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
MTSR Latest News, Press Relases and Analysis
All
Press Releases
7 days ago - By: Chartmill
- Mentions:
PFE
CNC
MOH
UNH
...
Shutdown Deal Breathes New Life Into Wall Street
7 days ago - By: Chartmill
- Mentions:
MOVE
IRWD
RUBI
COGT
...
Monday's pre-market session: top gainers and losers
15 hours ago - By: The Motley Fool
- Mentions:
PFE
Down 55%, Should You Buy the Dip on Pfizer?
3 days ago - By: The Motley Fool
- Mentions:
PFE
Is Pfizer Stock a Buy After This $10 Billion Acquisition?
3 days ago - By: Benzinga
- Mentions:
RAY
DAY
PSKY
NFLX
...
Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market
3 days ago - By: Benzinga
- Mentions:
LLY
NVO
PFE
MGRX
Ozempic Maker Novo Nordisk Faces Board Shakeup
4 days ago - By: Stocktwits
- Mentions:
NVO
PFE
LLY
Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO
4 days ago - By: Stocktwits
- Mentions:
CDTX
MRK
VRNA
PFE
...
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium
4 days ago - By: Stocktwits
- Mentions:
PFE
NVO
VZ
TSLA
Pfizer CEO Sees Metsera’s Drugs Hit Market As Early As 2028 After Completing Acquisition: Report
6 days ago - By: Stocktwits
- Mentions:
VKTX
PFE
NVO
LLY
...
‘Somebody Knows Something:’ Viking Therapeutics Stock Pops To Nearly 3-Month High As Retail Traders Intensely Speculate On M&A Scenarios
7 days ago - By: Investor's Business Daily
- Mentions:
PFE
NVO
Metsera Tumbles After The Pfizer-Novo Buyout Battle Ends At $10 Billion
7 days ago - By: Zacks Investment Research
- Mentions:
PFE
NVO
Pfizer Wins Obesity War Against NVO, to Buy Metsera for Around $10B
7 days ago - By: Bloomberg
- Mentions:
PFE
Pfizer Wins Obesity Drug Prize, With Trump Administration Assist
8 days ago - By: Stocktwits
- Mentions:
SPY
DIA
VSAT
RUM
Dow Futures Rise As Senate Votes To End Government Shutdown: MTSR, VSAT, RUM, TSM Among Stocks To Watch
8 days ago - By: Bloomberg
- Mentions:
PFE
LLY
Novo Nordisk Rises After Bowing Out of Metsera Takeover Battle
8 days ago - By: Stocktwits
- Mentions:
NVO
PFE
AKRO
VKTX
Novo Nordisk Loses Metsera Bidding War To Pfizer — But Retail Traders Aren’t Losing Faith
9 days ago - By: Bloomberg
- Mentions:
PFE
Novo’s CEO Turns to Next Targets After Losing Metsera to Pfizer
10 days ago - By: Metsera, Inc.
Pfizer and Metsera Enter into Merger Agreement Amendment; Metsera's Board of Directors Reaffirms Support of Merger with Pfizer
10 days ago - By: Bloomberg
- Mentions:
PFE
Pfizer Sweetens Its Offer for Metsera in Bidding War Against Novo
10 days ago - By: Zacks Investment Research
- Mentions:
PFE
AZN
NVO
Pfizer Discusses Drug Pricing Deal, Metsera Buyout Dispute on Q3 Call
10 days ago - By: Investor's Business Daily
- Mentions:
MS
LLY
NVO
VKTX
...
The Weight-Loss Drugs Craze Is Going Strong. But Stock Investors Should Know A Few Things.
11 days ago - By: Bloomberg
- Mentions:
PFE
Novo Nordisk CEO Challenges Pfizer to Raise its Bid for Metsera
11 days ago - By: Bloomberg
- Mentions:
LLY
Metsera Weight-Loss Drug Shows ‘Excellent’ Tolerability in Study
11 days ago - By: Bloomberg
- Mentions:
PFE
Novo Nordisk Sweetens Bid for Obesity Startup Metsera
18 days ago - By: Chartmill
- Mentions:
FMC
FMFC
EBS
IART
...
The market is filled with gapping stocks in Thursday's session.
Please enable JavaScript to continue using this application.